Patient satisfaction with a new smart and cost-effective Insulin Patch Pump System in type 1 diabetes patients using CSII and CGM or Flash glucose monitoring system

Patient satisfaction with a new smart and cost-effective Insulin Patch Pump System in type 1 diabetes patients using CSII and CGM or Flash glucose monitoring system - Patient satisfaction with Equil patchpump

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON55242

Enrollment

Registered

2020-11-09

Start date

2021-01-27

Completion date

Unknown

Last updated

2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 1 diabetes

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Male and female patients * T1D patients 18 years * Using CSII for 12 months or longer and needing a new pump within 6 months * Using CGM or FGM * Written informed consent obtained from the patient

Exclusion criteria

Exclusion criteria: * Pregnancy or pregnancy wish * Patients unable to understand spoken and written Dutch language * Patients on (hybrid) closed loop systems, i.e. Medtronic 670G pump * Patients on Medtronic 640G CSII pump that also use CGM-based *stop before low* * Patients with unstable glucose regulation, for example frequent hypo- or hyperglycaemia * Not able to perform the study according to the treating physician * Severe comorbidity and/or psychiatric disease

Design outcomes

Primary

Measure	Time frame
Patient satisfaction compared to current CSII system	—

Secondary

Measure	Time frame
Number of perceived dysfunctions, unexpected hypo- and hyperglycaemia, ketoacidosis	—

Countries

Netherlands

Outcome results